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Abstract
Identifying both the commonalities and differences in brain structures among psychiatric disorders is important for
understanding the pathophysiology. Recently, the ENIGMA-Schizophrenia DTI Working Group performed a large-scale
meta-analysis and reported widespread white matter microstructural alterations in schizophrenia; however, no similar cross-
disorder study has been carried out to date. Here, we conducted mega-analyses comparing white matter microstructural
differences between healthy comparison subjects (HCS; N= 1506) and patients with schizophrenia (N= 696), bipolar
disorder (N= 211), autism spectrum disorder (N= 126), or major depressive disorder (N= 398; total N= 2937 from
12 sites). In comparison with HCS, we found that schizophrenia, bipolar disorder, and autism spectrum disorder share
similar white matter microstructural differences in the body of the corpus callosum; schizophrenia and bipolar disorder
featured comparable changes in the limbic system, such as the fornix and cingulum. By comparison, alterations in tracts
connecting neocortical areas, such as the uncinate fasciculus, were observed only in schizophrenia. No significant difference
was found in major depressive disorder. In a direct comparison between schizophrenia and bipolar disorder, there were no
significant differences. Significant differences between schizophrenia/bipolar disorder and major depressive disorder were
found in the limbic system, which were similar to the differences in schizophrenia and bipolar disorder relative to HCS.
While schizophrenia and bipolar disorder may have similar pathological characteristics, the biological characteristics of
major depressive disorder may be close to those of HCS. Our findings provide insights into nosology and encourage further
investigations of shared and unique pathophysiology of psychiatric disorders.
Introduction
Classifying psychiatric disorders into distinct diagnoses
remains challenging, although Kraepelin dissociated
schizophrenia and bipolar disorder more than a century
ago. While psychiatric disorders, such as schizophrenia,
bipolar disorder, autism spectrum disorder, and major
depressive disorder, display specific symptoms, many of
their symptoms are shared by multiple disorders. Although
studies show common genetic abnormalities across psy-
chiatric disorders, the pathophysiological characteristics,
such as regional brain abnormalities in gray matter or
white matter across psychiatric disorders, are not fully
understood [1–6]. Identifying commonalities or differ-
ences in pathophysiological characteristics across psy-
chiatric disorders is important for the development of
more precise and objective diagnoses and the effective
development of new treatments.
* Ryota Hashimoto
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Previous diffusion tensor imaging (DTI) studies have
predominantly reported lower white matter fractional aniso-
tropy (FA) in psychiatric disorders [7–32]. Lower FA in the
prefrontal and temporal lobes and the fiber tracts connecting
these regions have commonly been identified in individuals
with schizophrenia [9–12]. Abnormalities in the cingulum and
corpus callosum have been widely reported in individuals
with bipolar disorder and autism spectrum disorder [13–32].
Some prior studies have also reported lower FA in the corpus
callosum in individuals with major depressive disorder [7, 8].
These white matter alterations have the potential to differ-
entiate pathophysiological characteristics between psychiatric
disorders. However, the considerable heterogeneity both in
the effect sizes and in the regional distribution of white matter
alterations reported across studies has limited the conclusions
that have been drawn to date. The heterogeneity between
studies may be due to differences in analytic methodology,
scanners, and study sample sizes [33].
To address variation in analysis methods and boost
statistical power, the Enhancing Neuroimaging Genetics
through Meta-Analysis (ENIGMA) Schizophrenia Working
Group performed the first worldwide meta-analysis pooling
schizophrenia-control effect sizes based on results from mul-
tiple sites generated using the same DTI, quality assurance,
and statistical analysis methods. Thus, Kelly et al. performed a
large-scale meta-analysis using the established ENIGMA-DTI
protocol, which harmonized the processing of diffusion
data from multiple sites (http://enigma.usc.edu/ongoing/dti-w
orking-group/), and identified white matter microstructural
alterations along with atlas-defined regions of interest (ROIs)
in patients with schizophrenia [34–37]. This study identified
widespread microstructural alterations, including the anterior
corona radiata, corpus callosum, cingulum, and fornix, in
individuals with schizophrenia. However, to the best of the
authors’ knowledge, no similar large-scale meta- or mega-
analysis study on white matter alterations across psychiatric
disorders has been carried out.
The present study, a research project by a Japanese
COCORO (Cognitive Genetics Collaborative Research
Organization) consortium, conducts a large, multisite, cross-
sectional investigation of white matter microstructural dif-
ferences among healthy comparison subjects (HCS) and
individuals with schizophrenia, bipolar disorder, autism
spectrum disorder, and major depressive disorder by using
mega-analytic methods similar to those of the study by
Kelly et al., which has already shown differences in white
matter microstructural alterations in the patients with schi-
zophrenia compared with the HCS [34]. As a new line of
work, we explored the common and distinct white matter
microstructural alterations across four major psychiatric
disorders. The first goal of this study is to replicate the
findings by Kelly et al [34]. The second goal is to examine
similarities and differences in white matter microstructure
among HCS and individuals with schizophrenia, bipolar
disorder, autism spectrum disorder, and major depressive
disorder.
Materials and methods
Participants
A total of 2937 individuals assessed at 12 sites participated
in the current cross-sectional COCORO cohort project. The
cohort included data from 1506 HCS, 696 individuals with
schizophrenia, 211 with bipolar disorder, 126 with autism
spectrum disorder, and 398 with major depressive disorder
(Table 1). Each participating site conducted magnetic
resonance imaging (MRI) scanning and obtained DTI with
one or more scanners and imaging protocols. A combina-
tion of one scanner and one imaging protocol was defined
as one “protocol,” and 18 protocols were included in the
current study. The data for HCS, schizophrenia, bipolar
disorder, autism spectrum disorder, and major depressive
disorder were obtained from 18, 15, 7, 4, and 7 protocols,
respectively. HCS for the patients with four psychiatric
diseases overlapped, and the HCS were not selected for
each group of psychiatric diseases. Each sample had already
contributed to prior neuroimaging studies [38–43]. Subject
inclusion and exclusion criteria by site are described
in Supplementary Method 1. Written informed consent,
approved by each local institutional review board, was
obtained from each subject prior to participation.
Image processing
Multisite raw DTI data were pooled at the University of
Tokyo where mega-analyses were performed. Detailed
imaging parameters for each protocol are shown in Sup-
plementary Method 2. Quality control included exclusion of
duplicate participants across sites; visual inspection of the
original T1-weighted images by two independent MRI
researchers and exclusion of images with any abnormal
findings (for example, large cerebellar cysts and cavum
septum pellucidum); checking of the scan parameters for
each DTI scan, and the exclusion of DTI data obtained with
incorrect parameters; exclusion of DTI data that failed
processing with FSL 5.0 (https://fsl.fmrib.ox.ac.uk/fsl)
tract-based spatial statistics (TBSS). Furthermore, we
excluded protocols with fewer than five participants in
either diagnostic group in the mega-analysis for investi-
gating group differences, and we excluded protocols with
fewer than 15 participants in each diagnostic group in the
mega-analysis for investigating correlations of the DTI
indices with duration of illness or medication to minimize
very small sample effects.
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Table 1 Basic characteristics
of the included protocols
Protocol name Healthy comparison subjects Individuals with schizophrenia
Age Age
N Male Female Mean s.d. N Male Female Mean s.d.
01. Osaka B 347 194 153 30.6 13.2 87 40 47 34.0 12.9
02. Osaka A 238 131 107 31.3 13.2 69 35 34 34.6 12.4
03. Kanazawa 113 72 41 33.9 9.9 111 44 67 39.9 12.5
04. Nagoya 124 77 47 36.5 9.8 53 29 24 43.0 9.9
05. Kyoto 75 46 29 28.6 9.4 52 24 28 36.4 9.0
06. Tokyo A 76 45 31 28.2 5.5 44 26 18 29.7 8.4
07. Toyama A 48 29 19 25.6 3.4 61 31 30 28.6 8.5
08. Hokkaido A 14 8 6 44.4 13.4 92 36 56 36.0 13.6
09. Hokkaido B 39 22 17 33.7 7.5 42 14 28 38.7 10.0
10. Tokyo D 51 17 34 39.2 7.9 16 10 6 29.4 9.1
11. Tokyo B 50 30 20 28.6 6.8 16 7 9 30.6 12.4
12. Tokushima 21 11 10 42.7 10.8 19 10 9 42.7 10.3
13. Tokyo C 27 10 17 38.0 9.5 8 5 3 37.9 4.2
14. Toyama B 11 4 7 26.8 3.6 15 10 5 28.6 9.1
15. Kyushu 6 4 2 35.8 11.8 11 9 2 54.6 9.7
Total 1240 700 540 32.0 11.6 696 330 366 36.0 12.2
Healthy comparison subjects Individuals with bipolar disorder
01. Osaka B 347 194 153 30.6 13.2 5 4 1 41.8 17.2
02. Kanazawa 113 72 41 33.9 9.9 35 18 17 46.0 15.0
03. Nagoya 124 77 47 36.5 9.8 22 9 13 50.3 13.8
04. Yamaguchi 116 47 69 45.3 19.1 18 10 8 41.7 12.5
05. Hiroshima 79 41 38 52.4 14.4 39 16 23 52.2 13.6
06. Hokkaido A 14 8 6 44.4 13.4 77 41 36 44.8 14.6
07. Tokyo D 51 17 34 39.2 7.9 15 7 8 32.5 7.7
Total 844 456 388 36.7 15.0 211 105 106 45.7 14.6
Healthy comparison subjects Individuals with autism spectrum
disorder
01. Osaka B 347 194 153 30.6 13.2 26 16 10 27.2 8.9
02. Osaka A 238 131 107 31.3 13.2 12 8 4 24.8 10.1
03. Nagoya 124 77 47 36.5 9.8 13 13 0 31.3 9.4
04. Showa 71 58 13 27.5 6.2 75 65 10 30.1 6.6
Total 780 460 320 31.4 12.4 126 102 24 29.1 7.9
Healthy comparison subjects Individuals with major depressive
disorder
01. Osaka B 347 194 153 30.6 13.2 16 5 11 49.1 14.9
02. Osaka A 238 131 107 31.3 13.2 5 3 2 48.6 20.1
03. Hokkaido A 14 8 6 44.4 13.4 163 81 82 47.9 17.5
04. Yamaguchi 116 47 69 45.3 19.1 57 24 33 51.7 12.5
05. Kanazawa 113 72 41 33.9 9.9 43 27 16 43.2 13.8
06. Hiroshima 79 41 38 52.4 14.4 84 31 53 50.0 13.8
07. Tokyo D 51 17 34 39.2 7.9 30 12 18 37.1 11.0
Total 958 510 448 35.4 15.3 398 183 215 47.7 15.6
White matter microstructural alterations across four major psychiatric disorders: mega-analysis study. . . 885
DTI image processing steps included head motion and
eddy current correction using eddy_correct (FSL 5.0). Esti-
mation of the following DTI indices were performed using
dti_fit (FSL 5.0): FA, mean diffusivity (MD), axial diffusivity
(AD), and radial diffusivity (RD). TBSS, using the ENIGMA-
DTI template and JHU ROIs, was applied to extract
local values of the DTI indices based on ENIGMA-DTI
protocols (http://enigma.ini.usc.edu/protocols/dti-protocols/).
FA is thought to indicate the underlying characteristics of
white matter microstructure, such as the directionality of
axonal fibers, diameter, density, and myelin sheath thickness.
FA is derived from the degree of anisotropy of the following
eigenvalues of the diffusion tensor: λ1, λ2, and λ3. The largest
eigenvalue (λ1), i.e., the AD, is a possible marker for axonal
injury. The average of the two smaller eigenvalues λ2 and λ3,
i.e., the RD, is considered an indicator of myelin damage. The
MD is the average of all three eigenvalues [44]. Finally, we
obtained the DTI indices of 25 ROIs: corpus callosum, genu
of the corpus callosum, body of the corpus callosum, sple-
nium of the corpus callosum, cingulum (cingulate gyrus),
cingulum (hippocampus), corona radiata, anterior corona
radiata, posterior corona radiata, superior corona radiata,
corticospinal tract, external capsule, fornix, fornix (crus)/stria
terminalis, internal capsule, anterior limb of the internal
capsule, posterior limb of the internal capsule, inferior fronto-
occipital fasciculus, retrolenticular part of the internal capsule,
posterior thalamic radiation, superior fronto-occipital fasci-
culus, superior longitudinal fasciculus, sagittal stratum, unci-
nate fasciculus, and average of the full skeleton’s FA (MD,
AD, and RD) [34].
Statistical analysis
All linear regression analyses were conducted using SPSS
version 23.0.0.0 (IBM Corp., Armonk, NY). Wolfers et al.
noted that group-level differences disguised biological het-
erogeneity and interindividual differences among patients
[45]. To address this issue, we compared the variability of
the DTI indices between the HCS group and the schizo-
phrenia, bipolar disorder, autism spectrum disorder, or major
depressive disorder groups, similar to Brugger et al. [46]
(Supplementary Method 3).
For comparison of the DTI indices, we calculated
Cohen’s d effect sizes in each of the 25 ROIs for FA, MD,
AD, and RD (four DTI indices) differences in HCS versus
individuals with schizophrenia, bipolar disorder, autism
spectrum disorder, and major depressive disorder after
including age, sex, age × sex, age2 and age2 × sex as
covariates for each cohort same as previous studies
[34, 47]. Next, we performed mega-analyses across
cohorts with Cohen’s d effect sizes using Metasoft soft-
ware (http://genetics.cs.ucla.edu/meta) similar to Kelly
et al. [34]. In addition, we conducted direct comparisons
among the patient groups in the same way to identify the
common and unique white matter microstructure altera-
tions across the diseases (Supplementary Table 1).
We evaluated the effect of duration of illness on the four
DTI indices. We calculated the β coefficients for associations
of DTI metrics with duration of illness, considering sex as a
covariate in regression analyses in patients with schizo-
phrenia, bipolar disorder, autism spectrum disorder, and major
depressive disorder for each cohort. For the individuals with
autism spectrum disorder, we employed age instead of the
duration of illness. Then, we performed mega-analyses across
cohorts with the β coefficients using the metacor package in R
(https://cran.r-project.org/web/packages/metacor/), which is
suitable for meta-analyses with the β coefficients.
Furthermore, we evaluated medication effects on all four
DTI indices. We calculated β coefficients of the chlorpro-
mazine equivalent dose, considering age, sex, age × sex,
age2, and age2 × sex as covariates in individuals with schi-
zophrenia for each sample. We calculated β coefficients of
lithium dose, considering age, sex, age × sex, age2, and
age2 × sex as covariates in patients with bipolar disorder for
each sample. We calculated β coefficients of the imipramine
equivalent dose, considering age, sex, age × sex, age2,
and age2 × sex as covariates in individuals with major
depressive disorder for each sample. Next, we performed
mega-analyses across samples with the β coefficients using
the metacor package in R (https://cran.r-project.org/web/pa
ckages/metacor/). The significance level was set at a Bon-
ferroni corrected p value of 0.002 (0.05/25). We conducted
a power analysis to estimate the sample sizes required to
detect an effect size with a previous study at a power of 0.80
and a one-tailed significance level of 0.002 (0.05/25), with
G*Power version 3.1.9.2 [34, 48].
Results
Variability ratio of the DTI indices
The number of DTI indices that the variability ratio was
significantly higher compared with HCS was larger in the
order of schizophrenia, major depressive disorder, bipolar
disorder, and autism spectrum disorder (Supplementary
Tables 2–17). However, I2 was in the upper 90% for almost
all DTI indices in all groups, and the heterogeneity in each
protocol was large; it was difficult to interpret the results.
DTI differences between healthy comparison
subjects and patients with schizophrenia
The results comparing DTI indices between HCS and indi-
viduals with schizophrenia are shown in Table 2, Fig. 1,
Supplementary Tables 18–21, and Supplementary Figs. 1–5.
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Of the 25 regions, 15 regions showed significantly lower FA
in patients with schizophrenia than in HCS. The largest
effect size was observed for lower FA in individuals with
schizophrenia in the anterior corona radiata, followed by the
body of the corpus callosum, corpus callosum, whole-brain
white matter skeleton (i.e., average FA), fornix, and cingu-
late gyrus. Significant FA reductions were also found in nine
additional ROIs in patients with schizophrenia. We found
significantly higher MD in the fornix, body of the corpus
callosum, whole-brain white matter skeleton (i.e., average
MD), corpus callosum, and uncinate fasciculus in indivi-
duals with schizophrenia than in HCS. Significantly higher
MD was also found in seven additional ROIs in patients with
schizophrenia than in HCS. We found significantly higher
AD in the fornix, uncinate fasciculus, superior corona
radiata, and posterior corona radiata in individuals with
schizophrenia than in HCS. We found significantly higher
RD in the fornix, anterior corona radiata, whole-brain white
matter skeleton (i.e., average RD), corpus callosum, body of
the corpus callosum, cingulate gyrus, and uncinate fascicu-
lus in patients with schizophrenia than in HCS. Significantly
higher RD was also found in 11 additional ROIs in indivi-
duals with schizophrenia than in HCS.
DTI differences between healthy comparison
subjects and patients with bipolar disorder, autism
spectrum disorder, and major depressive disorder
The results comparing DTI indices between HCS and indi-
viduals with bipolar disorder, autism spectrum disorder, or
major depressive disorder are shown in Table 2, Figs. 2 and 3,
Supplementary Tables 22–33, and Supplementary Figs. 4–17.
We found significantly lower FA in the cingulate gyrus,
higher MD in the fornix and body of the corpus callosum,
higher AD in the fornix and posterior limb of the internal
capsule, and lower RD in the fornix, body of the corpus
callosum, and the whole-brain white matter skeleton (i.e.,
average RD) in patients with bipolar disorder than in HCS.
Significantly lower FA was found in the body of the corpus
callosum in individuals with autism spectrum disorder than in
HCS. There were no significant differences in DTI indices in
patients with major depressive disorder compared with HCS.
DTI differences among the patient groups
The results comparing DTI indices among the patient
groups are shown in Supplementary Table 34–57. We found
Table 2 Brain region specificity of white matter microstructural alterations in psychiatric disorders
Limbic system–limbic system Limbic system/spine/brain
stem–cortex
Right cortex–left cortex Cortex–cortex (ipsilateral side)
Schizophrenia
Cingulum (cingulate gyrus; FA, RD) Anterior corona radiata
(FA, MD, RD)
Body of the corpus callosum
(FA, MD, RD)
Superior fronto-occipital
fasciculus (FA, MD, RD)
External capsule (FA, RD) Anterior limb of the internal
capsule (FA, RD)
Corpus callosum (FA,
MD, RD)
Superior longitudinal fasciculus
(FA, MD, RD)
Fornix (column and body of the fornix;
FA, MD, AD, RD)
Corona radiata (FA, MD, RD) Genu of the corpus callosum
(FA, MD, RD)
Uncinate fasciculus (MD,
AD, RD)
Fornix (crus)/Stria terminalis (FA, RD) Posterior corona radiata (MD,
AD, RD)
Posterior thalamic radiation
(FA, RD)
Superior corona radiata (MD,
AD, RD)
Sagittal stratum (FA, RD)
Bipolar disorder
Cingulum (cingulate gyrus; FA) Posterior limb of the internal
capsule (AD)
Body of the corpus callosum
(MD, RD)
Fornix (column and body of the
fornix; MD, AD, RD)
Autism spectrum disorder
Body of the corpus
callosum (FA)
Major depressive disorder
ROIs, which showed significant differences between patients with psychiatric disorders and healthy comparison subjects after adjusting age, sex,
age × sex, age2, and age2 × sex as covariates, were listed. The ROIs were classified according to the brain regions that they connect
FA fractional anisotropy, MD mean diffusivity, AD axial diffusivity, RD radial diffusivity, ROI region of interest
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significantly lower FA in the fornix, higher MD in the
fornix, higher AD in the fornix and superior corona radiata,
and higher RD in the fornix in individuals with schizo-
phrenia than in those with autism spectrum disorder. We
found significantly lower FA in the anterior limb of internal
capsule, corpus callosum, and superior fronto-occipital
fasciculus, higher MD in the body of corpus callosum,
corpus callosum, cingulum (cingulate gyrus), and splenium
of corpus callosum, and higher RD in body of corpus cal-
losum, corpus callosum, cingulum (cingulate gyrus), and
splenium of corpus callosum in individuals with schizo-
phrenia than in those with major depressive disorder.
Significantly higher MD and RD were found in the fornix in
the individuals with bipolar disorder than in those with
major depressive disorder. There were no significant dif-
ferences in DTI indices between patients with schizophrenia
and those with bipolar disorder, between individuals with
bipolar disorder and those with autism spectrum disorder,
and between individuals with autism spectrum disorder and
those with major depressive disorder.
Fig. 1 Differences in fractional anisotropy between the patients with
schizophrenia (SZ) and healthy comparison subjects (HCS). a Frac-
tional anisotropy (FA) differences between the patients with schizo-
phrenia and healthy comparison subjects (HCS) for 25 white matter
regions representing major fasciculi. The gradient bar indicates
Cohen’s d effect sizes after mega-analysis. b The figure on the right,
representing our results from COCORO, shows Cohen’s d effect sizes
after mega-analysis across 15 cohorts for FA differences in the patients
with schizophrenia (N= 696) versus HCS (N= 1240), after including
age, sex, age × sex, age2, and age2 × sex as covariates. Error bars
represent 95% confidence intervals. Regions with significant differ-
ences after adjusting for multiple regions tested [p < 0.002 (0.05/25)]
are highlighted in orange. The figure on the left represents the results
from the ENIGMA-Schizophrenia DTI consortium [29 cohorts for
FA differences in patients with schizophrenia (N= 1963) versus
HCS (N= 2359)]. The average FA represents the average FA
of the full skeleton. We generally replicated the results of
ENIGMA-Schizophrenia DTI. c Forest plot of effect sizes for 15
cohorts for average FA differences in the patients with schizophrenia
versus HCS. COCORO Cognitive Genetics Collaborative Research
Organization, ENIGMA-SZ-DTI Enhancing Neuroimaging Genetics
through Meta-Analysis consortium-Schizophrenia diffusion tensor
imaging, CC corpus callosum, GCC genu of the corpus callosum,
BCC body of the corpus callosum, SCC splenium of the corpus cal-
losum, CGC cingulum (cingulate gyrus), CGH cingulum (hippo-
campus), CR corona radiata, ACR anterior corona radiata, PCR
posterior corona radiata, SCR superior corona radiata, CST corti-
cospinal tract, EC external capsule, FX fornix, FX/ST fornix (crus)/
stria terminalis, IC internal capsule, ALIC anterior limb of the internal
capsule, PLIC posterior limb of the internal capsule, IFO inferior
fronto-occipital fasciculus, RLIC retrolenticular part of the internal
capsule, PTR posterior thalamic radiation, SFO superior fronto-
occipital fasciculus, SLF superior longitudinal fasciculus, SS sagittal
stratum, UNC uncinate fasciculus
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Relationships with duration of illness
The relationships between duration of illness and DTI
indices are shown in Supplementary Tables 58–73. The
duration of illness showed significant negative correlations
with FA in the anterior corona radiata, posterior thalamic
radiation, corona radiata, fornix, and body of the corpus
callosum, as well as in ten additional regions, in individuals
with schizophrenia. The duration of illness showed sig-
nificant negative correlations with FA in the anterior corona
radiata, genu of the corpus callosum, whole-brain white
matter skeleton (i.e., average FA), and fornix in patients
with bipolar disorder. The duration of illness (age) showed
significant negative correlations with FA in the posterior
thalamic radiation, genu of the corpus callosum,
retrolenticular part of the internal capsule, corona radiata,
posterior corona radiata, and internal capsule in individuals
with autism spectrum disorder. The duration of illness
showed significant negative correlations with FA in
the fornix, fornix (crus)/stria terminalis, superior fronto-
occipital fasciculus, and whole-brain white matter skeleton
(i.e., average FA) in the individuals with major depressive
disorder. The relationships between the duration of illness
and MD, AD, and RD were mostly consistent with those of
FA in each of the patient groups.
Relationships with medications
The relationships between medications and DTI indices are
shown in Supplementary Tables 74–85. There were no
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P<0.05/25
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A Fornix (FX; column and body) B Cingulum (CGC; cingulate gyrus)
D Uncinate fasciculus (UNC)C Body of corpus callosum (BCC)
Fig. 2 Effect sizes of the differences in DTI indices between patients
with psychiatric disorders and healthy comparison subjects in each
white matter region for the main findings. Significant differences in
regions after adjusting for multiple regions tested [p < 0.002 (0.05/25)]
are highlighted in orange. DTI diffusion tensor imaging, HCS healthy
comparison subjects, SZ schizophrenia, BPD bipolar disorder,
ASD autism spectrum disorder, MDD major depressive disorder,
FA fractional anisotropy, MD mean diffusivity, AD axial diffusivity,
RD radial diffusivity
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significant relationships between DTI indices and chlor-
promazine equivalent dose, lithium dose, or imipramine
equivalent dose in individuals with schizophrenia, bipolar
disorder, or major depressive disorder.
Discussion
Our study largely replicates the findings of the ENIGMA-
Schizophrenia Working Group (Fig. 1) [34]. For example,
the case-control effect size for average FA was d= –0.44 in
our study compared with d= –0.42 in the ENGIMA meta-
analysis [34]. The markedly lower FA in the anterior corona
radiata, corpus callosum, fornix, and cingulate gyrus regions
were well replicated in individuals with schizophrenia. We
replicated the significantly higher MD in the anterior corona
radiata, corpus callosum, and fornix regions, and further-
more, we are the first to report significantly higher MD in the
uncinate fasciculus. Although Kelly et al. reported sig-
nificantly higher AD only in the fornix, we have shown
significantly higher AD in three regions, such as the uncinate
fasciculus, in addition to fornix [34]. In this study, sig-
nificantly higher RD were found in the anterior corona
radiata, corpus callosum, fornix, cingulate gyrus, and unci-
nate fasciculus regions, as in the study by Kelly et al., and
we are the first to report significantly higher RD in the fornix
and cingulate gyrus [34]. Prior studies have reported lower
FA in the corpus callosum, fornix, and cingulum in indivi-
duals with bipolar disorder, higher AD and RD in the fornix
in patients with bipolar disorder, and lower FA, coupled with
MD, AD, and RD in the corpus callosum in individuals with
autism spectrum disorders; these results are consistent with
our findings [13–22, 24, 26, 28–30]. Furthermore, Chang
et al. found lower FA in the corpus callosum, fornix, and
cingulum both in 135 individuals with schizophrenia and 86
with bipolar disorder than in 156 healthy controls, but not in
108 with MDD; these results are consistent with our findings
[49]. The corpus callosum is an extensive bilateral hemi-
sphere relay center and connects extensive networks sub-
serving memory, attention, language, intelligence, and
emotional states; the fornix is located at the center of the
limbic system and contains pathways that connect brain
regions important for memory performance, emotion reg-
ulation, and reward processing, such as the hippocampus,
thalamus, and nucleus accumbens [50–52]. The cingulum
bundles, which are the primary intrahemispheric association
pathways for the medial cingulate cortex and temporal lobe
structures, are located above the corpus callosum. The cin-
gulum bundles connect the anterior cingulate to the posterior
cingulate cortex curve along with the splenium of the corpus
callosum, and they connect to the hippocampus [24]. Our
ROI for the cingulum was divided into two regions with the
cingulum around the cingulate gyrus and the cingulum
around the hippocampus. The ROI that we found a differ-
ence between the patients and HCS in this study was the
cingulum around the cingulate gyrus. We did not find
microstructural alterations in the uncinate fasciculus in
psychiatric disorders other than schizophrenia; however, a
prior meta-analysis reported lower FA in the uncinate fas-
ciculus in 117 individuals with autism spectrum disorder
compared with 125 HCS in six previously reported studies
[53]. This inconsistent result may be due to the difference in
mean age of participants, sample size or analysis method.
Two hundred forty-two individuals (mean age ranging from
5 to 28.5 years among the six studies) were included in the
study by Aoki et al., and 906 individuals [780 HCS (mean
age was 31.4) and 126 individuals with autism spectrum
disorder (mean age was 29.1)] were included in the current
study. Aoki et al. conducted a meta-analysis based on six
published studies, while we conducted a mega-analysis
based on jointly analyzed data [53].
In comparison with HCS, we found that patients with
schizophrenia, bipolar disorder, or autism spectrum disorder
have common white matter alterations in the body of the
FA
RD
FA
RDRD
FA
RD
FA
FX
CGC
BCC
UNC
0.6
0
0.5
0.2
0.3
0.4
0.1
A
bsolute value of effect size
Fig. 3 White matter microstructural alterations across psychiatric dis-
orders. Color scales indicate the absolute value of Cohen’s d effect size
of the DTI indices (FA, MD, AD, and RD) between each patient
population (schizophrenia, bipolar disorder, autism spectrum disorder,
and major depressive disorder) and healthy comparison subjects in
each region of interest (UNC, BCC, CGC, and FX). Gray dots indicate
statistical significance. The patients with schizophrenia, bipolar dis-
order, and autism spectrum disorder have common white matter
alterations in the body of the corpus callosum; the patients with
schizophrenia and bipolar disorder have common white matter
alterations in the limbic system, such as the fornix and the cingulum;
microstructural alterations in white matter regions that connect neo-
cortical areas, such as uncinate fasciculus, were specific to patients
with schizophrenia. DTI diffusion tensor imaging, SZ schizophrenia,
BPD bipolar disorder, MDD major depressive disorder, ASD autism
spectrum disorder, FA fractional anisotropy, MD mean diffusivity,
AD axial diffusivity, RD radial diffusivity, UNC uncinate fasciculus,
BCC body of the corpus callosum, CGC cingulum (cingulate gyrus),
FX fornix
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corpus callosum (Fig. 3). Previous genetic studies have
shown phenotypic and genetic overlap across psychiatric
disorders, for example, between schizophrenia and bipolar
disorder, between autism spectrum disorders and schizo-
phrenia, and between autism spectrum disorders and bipolar
disorder [1–6]. Our findings of common white matter
alterations among individuals with schizophrenia, bipolar
disorder, and autism spectrum disorders may in part reflect
genetic overlap. Furthermore, patients with schizophrenia
and bipolar disorder have common alterations in white
matter microstructure in the limbic system, i.e., the fornix
and cingulum; microstructural alterations in white matter
regions that connect neocortical areas, such as the uncinate
fasciculus, were specific to individuals with schizophrenia.
Lower volumes in neocortical regions, such as the frontal
and temporal gyri, which are repeatedly reported in patients
with schizophrenia, may be associated with the specificity
of the microstructural alterations in white matter regions
connecting these neocortical regions in individuals with
schizophrenia [54–56]. It is known that not only individuals
with schizophrenia but also those with bipolar disorder
show cognitive impairment, albeit less severe in the latter
case [57–59]. We speculate that the common cognitive
dysfunctions across psychotic disorders are potentially
associated with the common alterations in the limbic system
and corpus callosum across psychiatric disorders, which
have important roles in memory performance. However,
specific alterations in white matter regions connecting
neocortical areas may be related to more severe cognitive
decline in patients with schizophrenia. Our hypothesis is
supported by previous findings that white matter alterations
in the anterior corona radiata and corpus callosum are
associated with social dysfunction in individuals with
schizophrenia and by current our results, which have shown
significant correlations between the duration of illness and
alterations in white matter tracts connecting neocortical
regions, including the anterior corona radiata and uncinate
fasciculus, in patients with schizophrenia [40]. These find-
ings may suggest that the gradual progressive impairment of
white matter microstructure may be associated with the
gradual functional decline in individuals with schizophrenia
[60]. The lack of white matter alterations in the patients
with major depressive disorder may reflect different
pathological characteristics between the patients with major
depressive disorder and those with other psychiatric dis-
orders. In addition, only one region of white matter altera-
tion was found in individuals with autism spectrum
disorders, and they also have the potential to have different
pathological characteristics with other psychiatric disorders.
Individuals with major depressive disorder and autism
spectrum disorders may be a heterogeneous population, and
some of them may have biological characteristics similar to
those of HCS.
In a direct comparison between individuals with schi-
zophrenia and those with bipolar disorder, there were
no significant white matter microstructural differences.
Significant differences in the limbic system were found
between schizophrenia and major depressive disorder,
between schizophrenia and autism spectrum disorders, and
between bipolar disorder and major depressive disorder.
Furthermore, those regions were similar to the regions
where the differences were observed between individuals
with schizophrenia and HCS and between bipolar disorder
and HCS. Because the biological characteristics of major
depressive disorder and autism spectrum disorder are close
to those of HCS, we may have found similar patterns
between them. The Diagnostic and Statistical Manual of
Mental Disorders, fifth edition (DSM-5), which was pub-
lished in 2013, originally aimed to use biological indicators
for the diagnosis of psychiatric disorders; however, this goal
had not been reached, and therefore, the DSM-5 still relies
on symptomatic diagnosis [61]. Our results may support the
diagnosis of bipolar disorders being separated from those of
depressive disorders in DSM-5. Our findings of common or
unique white matter alteration across psychiatric disorders
may contribute to the further development of new diag-
nostic methods when considered with other intermediate
phenotypes in psychiatric disorders.
Relationships between duration of illness and white
matter indices were widespread in patients with schizo-
phrenia and present in those with bipolar disorder, autism
spectrum disorder, and major depressive disorder. Our
findings of those significant relationships in white matter
tracts, such as the anterior corona radiata and corpus cal-
losum in individuals with schizophrenia, were similar to
those reported by the ENIGMA-Schizophrenia meta-
analysis [34]. Because multiple DTI indices in the regions,
such as anterior corona radiata, body of the corpus callo-
sum, fornix, and uncinate fasciculus, were correlated with
duration of illness in individuals with schizophrenia and
bipolar disorder, progressive pathological change may
cause more severe axonal injury and myelin damage in
those regions in those patients. In contrast, there were no
significant associations between medication doses and the
DTI indices in the patients with schizophrenia, bipolar
disorder, or major depressive disorder.
Some limitations of our study must be noted. First, the
effects of MRI scanner differences on our findings cannot
be completely ruled out; however, we minimized this effect
using the mega-analysis method. It may be desirable for
classification analyses to be performed using the DTI
indices among the patient groups; however, there are
methodological limitations due to the large effect of MRI
scanner differences. Second, although the medication effect
on the DTI indices cannot be completely ruled out, we
found no significant medication dose-related effects on the
White matter microstructural alterations across four major psychiatric disorders: mega-analysis study. . . 891
DTI indices using regression analysis. Third, associations
between symptom severity and effect sizes of DTI indices
were not investigated in this study. Investigating relation-
ships of DTI indices with cognitive function, depressive
state, manic state, and psychotic syndrome will be fruitful
for understanding common or unique pathologies across
psychotic disorders in the future. Fourth, genetic or envir-
onmental effects on the DTI indices were not investigated in
the current study. It is known that lower birth weight among
individuals who later develop schizophrenia than among
HCS, and a previous study has shown that birth weight
influences the white matter volume in patients with schi-
zophrenia [62–64]. Future research investigating the asso-
ciation between birth weight and DTI indices may be useful
to show the effects of gene and environment interaction on
white matter alteration in patients with psychotic disorders.
In conclusion, we have shown white matter micro-
structural alterations across psychiatric disorders. The
widespread white matter microstructural alterations in lim-
bic and cortical regions in schizophrenia reported by Kelly
et al. were successfully replicated in the present study [34].
Furthermore, in comparison with HCS, we revealed that
patients with schizophrenia, bipolar disorder and autism
spectrum disorder have shared common white matter
alterations in the body of the corpus callosum; individuals
with schizophrenia and bipolar disorder have common
white matter alterations in the limbic system, including in
the fornix and cingulum; and microstructural alterations in
white matter regions that connect neocortical areas, such as
uncinate fasciculus, were specific to schizophrenia; there
was no significant difference in major depressive disorder.
In a direct comparison between schizophrenia and bipolar
disorder, there were no significant differences; significant
differences between schizophrenia/bipolar disorder and
major depressive disorder were found in the limbic system,
which were similar to the difference between schizophrenia/
bipolar disorder and HCS. Our findings suggest that
pathological characteristics may be similar between schi-
zophrenia and bipolar disorder; however, the biological
characteristics of major depressive disorder may be close to
those of HCS. Our findings of common or unique white
matter alteration across psychiatric disorders provide
insights into nosology and encourage the investigation of
pathophysiology for psychiatric disorders.
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